BioSpace News Archive

Esperion announced that bempedoic acid was included in the “Top 10 Medical Innovations for 2020” at Cleveland Clinic’s 2019 Medical Innovation Summit on Wednesday, October 23rd.

The XXIV World Congress of Neurology is bringing together leading voices in migraine research and advocacy to share vital insights on the global impact of migraine in the workplace.

The Society for Medical Decision Making awarded Regenstrief Institute researcher Stephen Downs, M.D., M.S., with the John M. Eisenberg Award for Practical Application of Medical Decision Making Research.

CELLINK has announced the opening of an office in Lyon, France to strengthen their relationships with customers locally and throughout Europe.

Amarantus Bioscience Holdings, Inc. announced it has entered into a binding term sheet to license its therapeutic assets to Emerald Organic Growth, Inc., a fully-integrated, CBD-based health sciences company launching branded products via its nationwide distribution channels.

PurpleStride Supports the Pancreatic Cancer Action Network’s Urgent Mission to Save Lives and

Arcutis Also Announces Enrollment of Last Patient in 52-Week Long-term Safety Study of ARQ-151 Cream as a Potential Topical Treatment for Plaque Psoriasis

ImmunoQure AG, a biotechnology company focused on the development of autoantibodies as therapeutics to treat human diseases and Memo Therapeutics AG, a biotechnology company focused on the discovery and development of therapeutic antibodies from cognate paired antibody libraries today announced the establishment of a collaborative partnership to create libraries from APS-1 memory B cells.

Motif Bio plc announced that the Company has signed an agreement with the Walter Reed Army Institute of Research to conduct pre-clinical testing to evaluate novel combinations with iclaprim to improve safety and efficacy administered by a novel enhanced aerosol technology.

Founder Mike Wenger to Join Staff as Vice President of Patient Engagement